Copyright Reports & Markets. All rights reserved.

Global CT Contrast Media Market Research Report 2021

Request for Sample of this report
Buy now

1 CT Contrast Media Market Overview

  • 1.1 Product Overview and Scope of CT Contrast Media
  • 1.2 CT Contrast Media Segment by Type
    • 1.2.1 Global CT Contrast Media Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Iohexol
    • 1.2.3 Iodixanol
    • 1.2.4 Iopamidol
    • 1.2.5 Ioversol
    • 1.2.6 Others
  • 1.3 CT Contrast Media Segment by Application
    • 1.3.1 Global CT Contrast Media Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
  • 1.4 Global CT Contrast Media Market Size Estimates and Forecasts
    • 1.4.1 Global CT Contrast Media Revenue 2016-2027
    • 1.4.2 Global CT Contrast Media Sales 2016-2027
    • 1.4.3 CT Contrast Media Market Size by Region: 2016 Versus 2021 Versus 2027

2 CT Contrast Media Market Competition by Manufacturers

  • 2.1 Global CT Contrast Media Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global CT Contrast Media Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global CT Contrast Media Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers CT Contrast Media Manufacturing Sites, Area Served, Product Type
  • 2.5 CT Contrast Media Market Competitive Situation and Trends
    • 2.5.1 CT Contrast Media Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest CT Contrast Media Players Market Share by Revenue
    • 2.5.3 Global CT Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 CT Contrast Media Retrospective Market Scenario by Region

  • 3.1 Global CT Contrast Media Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global CT Contrast Media Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America CT Contrast Media Market Facts & Figures by Country
    • 3.3.1 North America CT Contrast Media Sales by Country
    • 3.3.2 North America CT Contrast Media Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe CT Contrast Media Market Facts & Figures by Country
    • 3.4.1 Europe CT Contrast Media Sales by Country
    • 3.4.2 Europe CT Contrast Media Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific CT Contrast Media Market Facts & Figures by Region
    • 3.5.1 Asia Pacific CT Contrast Media Sales by Region
    • 3.5.2 Asia Pacific CT Contrast Media Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 China Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America CT Contrast Media Market Facts & Figures by Country
    • 3.6.1 Latin America CT Contrast Media Sales by Country
    • 3.6.2 Latin America CT Contrast Media Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa CT Contrast Media Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa CT Contrast Media Sales by Country
    • 3.7.2 Middle East and Africa CT Contrast Media Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global CT Contrast Media Historic Market Analysis by Type

  • 4.1 Global CT Contrast Media Sales Market Share by Type (2016-2021)
  • 4.2 Global CT Contrast Media Revenue Market Share by Type (2016-2021)
  • 4.3 Global CT Contrast Media Price by Type (2016-2021)

5 Global CT Contrast Media Historic Market Analysis by Application

  • 5.1 Global CT Contrast Media Sales Market Share by Application (2016-2021)
  • 5.2 Global CT Contrast Media Revenue Market Share by Application (2016-2021)
  • 5.3 Global CT Contrast Media Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 GE Healthcare
    • 6.1.1 GE Healthcare Corporation Information
    • 6.1.2 GE Healthcare Description and Business Overview
    • 6.1.3 GE Healthcare CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 GE Healthcare CT Contrast Media Product Portfolio
    • 6.1.5 GE Healthcare Recent Developments/Updates
  • 6.2 Bayer
    • 6.2.1 Bayer Corporation Information
    • 6.2.2 Bayer Description and Business Overview
    • 6.2.3 Bayer CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Bayer CT Contrast Media Product Portfolio
    • 6.2.5 Bayer Recent Developments/Updates
  • 6.3 Bracco Imaging
    • 6.3.1 Bracco Imaging Corporation Information
    • 6.3.2 Bracco Imaging Description and Business Overview
    • 6.3.3 Bracco Imaging CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Bracco Imaging CT Contrast Media Product Portfolio
    • 6.3.5 Bracco Imaging Recent Developments/Updates
  • 6.4 Guerbet Group
    • 6.4.1 Guerbet Group Corporation Information
    • 6.4.2 Guerbet Group Description and Business Overview
    • 6.4.3 Guerbet Group CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Guerbet Group CT Contrast Media Product Portfolio
    • 6.4.5 Guerbet Group Recent Developments/Updates
  • 6.5 Hengrui Medicine
    • 6.5.1 Hengrui Medicine Corporation Information
    • 6.5.2 Hengrui Medicine Description and Business Overview
    • 6.5.3 Hengrui Medicine CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Hengrui Medicine CT Contrast Media Product Portfolio
    • 6.5.5 Hengrui Medicine Recent Developments/Updates
  • 6.6 Lantheus
    • 6.6.1 Lantheus Corporation Information
    • 6.6.2 Lantheus Description and Business Overview
    • 6.6.3 Lantheus CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Lantheus CT Contrast Media Product Portfolio
    • 6.6.5 Lantheus Recent Developments/Updates
  • 6.7 YRPG
    • 6.6.1 YRPG Corporation Information
    • 6.6.2 YRPG Description and Business Overview
    • 6.6.3 YRPG CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 YRPG CT Contrast Media Product Portfolio
    • 6.7.5 YRPG Recent Developments/Updates
  • 6.8 BeiLu Pharma
    • 6.8.1 BeiLu Pharma Corporation Information
    • 6.8.2 BeiLu Pharma Description and Business Overview
    • 6.8.3 BeiLu Pharma CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 BeiLu Pharma CT Contrast Media Product Portfolio
    • 6.8.5 BeiLu Pharma Recent Developments/Updates
  • 6.9 Sanochemia
    • 6.9.1 Sanochemia Corporation Information
    • 6.9.2 Sanochemia Description and Business Overview
    • 6.9.3 Sanochemia CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Sanochemia CT Contrast Media Product Portfolio
    • 6.9.5 Sanochemia Recent Developments/Updates
  • 6.10 Tyco Healthcare
    • 6.10.1 Tyco Healthcare Corporation Information
    • 6.10.2 Tyco Healthcare Description and Business Overview
    • 6.10.3 Tyco Healthcare CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Tyco Healthcare CT Contrast Media Product Portfolio
    • 6.10.5 Tyco Healthcare Recent Developments/Updates
  • 6.11 Imax
    • 6.11.1 Imax Corporation Information
    • 6.11.2 Imax CT Contrast Media Description and Business Overview
    • 6.11.3 Imax CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Imax CT Contrast Media Product Portfolio
    • 6.11.5 Imax Recent Developments/Updates
  • 6.12 Grupo Juste
    • 6.12.1 Grupo Juste Corporation Information
    • 6.12.2 Grupo Juste CT Contrast Media Description and Business Overview
    • 6.12.3 Grupo Juste CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Grupo Juste CT Contrast Media Product Portfolio
    • 6.12.5 Grupo Juste Recent Developments/Updates
  • 6.13 Daiichi Sankyo
    • 6.13.1 Daiichi Sankyo Corporation Information
    • 6.13.2 Daiichi Sankyo CT Contrast Media Description and Business Overview
    • 6.13.3 Daiichi Sankyo CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Daiichi Sankyo CT Contrast Media Product Portfolio
    • 6.13.5 Daiichi Sankyo Recent Developments/Updates
  • 6.14 Takeda
    • 6.14.1 Takeda Corporation Information
    • 6.14.2 Takeda CT Contrast Media Description and Business Overview
    • 6.14.3 Takeda CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Takeda CT Contrast Media Product Portfolio
    • 6.14.5 Takeda Recent Developments/Updates
  • 6.15 Fuji Pharma
    • 6.15.1 Fuji Pharma Corporation Information
    • 6.15.2 Fuji Pharma CT Contrast Media Description and Business Overview
    • 6.15.3 Fuji Pharma CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Fuji Pharma CT Contrast Media Product Portfolio
    • 6.15.5 Fuji Pharma Recent Developments/Updates
  • 6.16 Towaseiyaku
    • 6.16.1 Towaseiyaku Corporation Information
    • 6.16.2 Towaseiyaku CT Contrast Media Description and Business Overview
    • 6.16.3 Towaseiyaku CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Towaseiyaku CT Contrast Media Product Portfolio
    • 6.16.5 Towaseiyaku Recent Developments/Updates
  • 6.17 Hikari Pharmaceutical
    • 6.17.1 Hikari Pharmaceutical Corporation Information
    • 6.17.2 Hikari Pharmaceutical CT Contrast Media Description and Business Overview
    • 6.17.3 Hikari Pharmaceutical CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Hikari Pharmaceutical CT Contrast Media Product Portfolio
    • 6.17.5 Hikari Pharmaceutical Recent Developments/Updates
  • 6.18 Consentis Diagnostics GmbH
    • 6.18.1 Consentis Diagnostics GmbH Corporation Information
    • 6.18.2 Consentis Diagnostics GmbH CT Contrast Media Description and Business Overview
    • 6.18.3 Consentis Diagnostics GmbH CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Consentis Diagnostics GmbH CT Contrast Media Product Portfolio
    • 6.18.5 Consentis Diagnostics GmbH Recent Developments/Updates
  • 6.19 T2Pharma
    • 6.19.1 T2Pharma Corporation Information
    • 6.19.2 T2Pharma CT Contrast Media Description and Business Overview
    • 6.19.3 T2Pharma CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 T2Pharma CT Contrast Media Product Portfolio
    • 6.19.5 T2Pharma Recent Developments/Updates

7 CT Contrast Media Manufacturing Cost Analysis

  • 7.1 CT Contrast Media Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of CT Contrast Media
  • 7.4 CT Contrast Media Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 CT Contrast Media Distributors List
  • 8.3 CT Contrast Media Customers

9 CT Contrast Media Market Dynamics

  • 9.1 CT Contrast Media Industry Trends
  • 9.2 CT Contrast Media Growth Drivers
  • 9.3 CT Contrast Media Market Challenges
  • 9.4 CT Contrast Media Market Restraints

10 Global Market Forecast

  • 10.1 CT Contrast Media Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of CT Contrast Media by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of CT Contrast Media by Type (2022-2027)
  • 10.2 CT Contrast Media Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of CT Contrast Media by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of CT Contrast Media by Application (2022-2027)
  • 10.3 CT Contrast Media Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of CT Contrast Media by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of CT Contrast Media by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Iohexol
    Iodixanol
    Iopamidol
    Ioversol
    Others

    Segment by Application
    Hospitals
    Clinics

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    China Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    GE Healthcare
    Bayer
    Bracco Imaging
    Guerbet Group
    Hengrui Medicine
    Lantheus
    YRPG
    BeiLu Pharma
    Sanochemia
    Tyco Healthcare
    Imax
    Grupo Juste
    Daiichi Sankyo
    Takeda
    Fuji Pharma
    Towaseiyaku
    Hikari Pharmaceutical
    Consentis Diagnostics GmbH
    T2Pharma

    Buy now